Skip to content

Michelle Allen, FNP

NPI 1922540822ActiveIndividual· Nurse Practitioner· Dallas, TX

Nurse Practitioner (FNP) in Dallas, Texas, licensed in TX, with an NPI issued in November 2016. Part D covered 113 prescriptions written in 2024, 78% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 13 companies reporting payments in 2025, $818.61 in all, mostly food and beverage.

Overview

NPI1922540822
StatusActive
Entity typeIndividual
CredentialFNP
Sole proprietorNo
NPI issuedNov 8, 2016
Last updated in NPPESJan 12, 2024
Certified by providerJan 12, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Nurse Practitioner Primary363L00000XAP131362TX
Nurse Practitioner, Family363LF0000XAP131362TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nurse Practitioner (TX)

Part D prescriptions in 2024

Prescriptions (claims)113 · 114 30-day fills
Patients24
Total drug cost$11,924
Generic share78% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$818.61 · 31 payments from 13 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$818.61 · 31 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other nurse practitioners in Dallas

All 483 nurse practitioners in Dallas · All nurse practitioners in Texas